Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 28

1.

Recent advances in the understanding of myelodysplastic syndromes with ring sideroblasts.

Malcovati L, Cazzola M.

Br J Haematol. 2016 Sep;174(6):847-58. doi: 10.1111/bjh.14215. Epub 2016 Jul 8. Review.

PMID:
27391606
2.

Monitoring of the Clonal Fraction by Fluorescence In Situ Hybridization in Myelodysplastic Syndrome: Comparison With International Working Group Treatment Response Criteria.

Park JH, Kim M, Kong SY, Yoon SS, Lee DS.

Arch Pathol Lab Med. 2016 Jun;140(6):560-9. doi: 10.5858/arpa.2015-0150-OA.

PMID:
27232348
3.

Spectrum of the WHO Classification De Novo Myelodysplastic Syndrome: Experience from Southern Pakistan.

Sultan S, Irfan SM, Jawed SN.

Asian Pac J Cancer Prev. 2016;17(3):1049-52.

4.

[Serum Erythropoietin as Prognostic Marker in Myelodysplastic Syndromes].

Cortesão E, Tenreiro R, Ramos S, Pereira M, César P, Carda JP, Gomes M, Rito L, Magalhães E, Gonçalves AC, Silva NC, Geraldes C, Pereira A, Ribeiro L, Nascimento Costa JM, Ribeiro AB.

Acta Med Port. 2015 Nov-Dec;28(6):720-5. Epub 2015 Dec 31. Portuguese.

5.

Is chronic neutropenia always a benign disease? Evidences from a 5-year prospective study.

Fattizzo B, Zaninoni A, Consonni D, Zanella A, Gianelli U, Cortelezzi A, Barcellini W.

Eur J Intern Med. 2015 Oct;26(8):611-5. doi: 10.1016/j.ejim.2015.05.019. Epub 2015 Jun 8.

PMID:
26066399
6.

In patients with myelodysplastic syndromes with del(5q), factors other than age and sex contribute to the prognostic advantage, which diminishes over time.

Lauseker M, Schemenau J, Strupp C, Kündgen A, Gattermann N, Hasford J, Germing U.

Br J Haematol. 2015 Sep;170(5):687-93. doi: 10.1111/bjh.13496. Epub 2015 May 11.

PMID:
25960152
7.

[Analysis of the karyotype abnormalities and its prognostic in 298 patients with myelodysplastic syndrome].

Yan X, Wei J, Wang J, Ren Y, Zhou X, Mei C, Ye L, Xie L, Hu C, Jin J, Tong H.

Zhonghua Xue Ye Xue Za Zhi. 2015 Apr;36(4):297-301. doi: 10.3760/cma.j.issn.0253-2727.2015.04.008. Chinese.

PMID:
25916290
8.

Refractory thrombocytopenia and neutropenia: a diagnostic challenge.

Gyan E, Dreyfus F, Fenaux P.

Mediterr J Hematol Infect Dis. 2015 Feb 18;7(1):e2015018. doi: 10.4084/MJHID.2015.018. eCollection 2015. Review.

9.

Interobserver variance in myelodysplastic syndromes with less than 5 % bone marrow blasts: unilineage vs. multilineage dysplasia and reproducibility of the threshold of 2 % blasts.

Font P, Loscertales J, Soto C, Ricard P, Novas CM, Martín-Clavero E, López-Rubio M, Garcia-Alonso L, Callejas M, Bermejo A, Benavente C, Ballesteros M, Cedena T, Calbacho M, Urbina R, Villarrubia J, Gil S, Bellón JM, Diez-Martin JL, Villegas A.

Ann Hematol. 2015 Apr;94(4):565-73. doi: 10.1007/s00277-014-2252-4. Epub 2014 Nov 13.

PMID:
25387664
10.

Late hematological improvement of myelodysplastic syndrome following treatment with 5-azacitidine therapy.

Takaoka K, Hangaishi A, Ito A, Morioka T, Kida M, Usuki K.

Intern Med. 2014;53(19):2241-3.

11.

Over-expression of cancerous inhibitor of PP2A (CIP2A) in bone marrow cells from patients with a group of high-risk myelodysplastic syndromes.

Li N, Abe S, Kurata M, Abe-Suzuki S, Onishi I, Kirimura S, Murayama T, Hidaka M, Kawano F, Kitagawa M.

Pathol Oncol Res. 2014 Apr;20(2):399-407. doi: 10.1007/s12253-013-9709-y. Epub 2013 Oct 26.

PMID:
24163288
12.

Isolated deletion of the long arm of chromosome 20 [del(20q12)] in myelodysplastic syndrome: a case report and literature review.

Padhi S, Varghese RG, Phansalkar MD, Sarangi R.

Singapore Med J. 2013 Sep;54(9):e185-9. Review.

13.

[Myelodysplastic syndrome classification].

Ghariani I, Braham N, Hassine M, Kortas M.

Ann Biol Clin (Paris). 2013 Mar-Apr;71(2):139-44. doi: 10.1684/abc.2013.0804. Review. French.

PMID:
23587576
14.

Increased plasma thrombopoietin levels in patients with myelodysplastic syndrome: a reliable marker for a benign subset of bone marrow failure.

Seiki Y, Sasaki Y, Hosokawa K, Saito C, Sugimori N, Yamazaki H, Takami A, Nakao S.

Haematologica. 2013 Jun;98(6):901-7. doi: 10.3324/haematol.2012.066217. Epub 2013 Feb 12.

15.

Single nucleotide polymorphism array-based karyotyping in acute myeloid leukemia or myelodysplastic syndrome with trisomy 8 as the sole chromosomal abnormality.

Hahm C, Mun YC, Seong CM, Han SH, Chung WS, Huh J.

Acta Haematol. 2013;129(3):154-8. doi: 10.1159/000343420. Epub 2012 Nov 30.

PMID:
23208021
16.

Inter-observer variance with the diagnosis of myelodysplastic syndromes (MDS) following the 2008 WHO classification.

Font P, Loscertales J, Benavente C, Bermejo A, Callejas M, Garcia-Alonso L, Garcia-Marcilla A, Gil S, Lopez-Rubio M, Martin E, Muñoz C, Ricard P, Soto C, Balsalobre P, Villegas A.

Ann Hematol. 2013 Jan;92(1):19-24. doi: 10.1007/s00277-012-1565-4. Epub 2012 Sep 5.

PMID:
22948274
17.

Prediction of progression from refractory cytopenia with unilineage dysplasia by analysis of bone marrow blast cell composition.

Oka S, Muroi K, Fujiwara S, Oh I, Matsuyama T, Ohmine K, Suzuki T, Ozaki K, Mori M, Nagai T, Ozawa K, Hanafusa T.

J Clin Exp Hematop. 2012;52(1):63-6.

18.

NAD(P)H: quinone oxidoreductase 1 deficiency conjoint with marginal vitamin C deficiency causes cigarette smoke induced myelodysplastic syndromes.

Das A, Dey N, Ghosh A, Das T, Chatterjee IB.

PLoS One. 2011;6(5):e20590. doi: 10.1371/journal.pone.0020590. Epub 2011 May 31.

19.

Role of bone marrow imprints in haematological diagnosis: a detailed study of 3781 cases.

Gong X, Lu X, Wu X, Xu R, Tang Q, Xu G, Wang L, Zhang X, Zhao X.

Cytopathology. 2012 Apr;23(2):86-95. doi: 10.1111/j.1365-2303.2010.00825.x. Epub 2010 Dec 3.

PMID:
21129051
20.

[Value of imprint in bone marrow morphological examination].

Gong XB, Lu XG, Xu GB, Wu XG, Wang L, Zhang XH, Zhu L, Wang WQ.

Zhonghua Yi Xue Za Zhi. 2010 Jun 8;90(22):1531-6. Chinese.

PMID:
20973233
Items per page

Supplemental Content

Loading ...
Write to the Help Desk